Mamoru Kyogashima

1.5k total citations
59 papers, 1.2k citations indexed

About

Mamoru Kyogashima is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Mamoru Kyogashima has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 18 papers in Cell Biology and 9 papers in Organic Chemistry. Recurrent topics in Mamoru Kyogashima's work include Sphingolipid Metabolism and Signaling (19 papers), Glycosylation and Glycoproteins Research (18 papers) and Proteoglycans and glycosaminoglycans research (13 papers). Mamoru Kyogashima is often cited by papers focused on Sphingolipid Metabolism and Signaling (19 papers), Glycosylation and Glycoproteins Research (18 papers) and Proteoglycans and glycosaminoglycans research (13 papers). Mamoru Kyogashima collaborates with scholars based in Japan, China and United States. Mamoru Kyogashima's co-authors include Yutaka Kariya, Victor Ginsburg, Reiji Kannagi, H C Krivan, Atsushi Hara, Tadashi Ishii, Toshifumi Aoyama, T. Kaneko, Kiyoshi Suzuki and Masayuki Ishihara and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Analytical Biochemistry.

In The Last Decade

Mamoru Kyogashima

58 papers receiving 1.2k citations

Peers

Mamoru Kyogashima
James W. Brodrick United States
Ralph Paxton United States
Jill D. Coursen United States
Nelson Hsia United States
Howard Wong United States
Jong-Young Kwak South Korea
Mamoru Kyogashima
Citations per year, relative to Mamoru Kyogashima Mamoru Kyogashima (= 1×) peers Tatsunari Nishi

Countries citing papers authored by Mamoru Kyogashima

Since Specialization
Citations

This map shows the geographic impact of Mamoru Kyogashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Kyogashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Kyogashima more than expected).

Fields of papers citing papers by Mamoru Kyogashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Kyogashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Kyogashima. The network helps show where Mamoru Kyogashima may publish in the future.

Co-authorship network of co-authors of Mamoru Kyogashima

This figure shows the co-authorship network connecting the top 25 collaborators of Mamoru Kyogashima. A scholar is included among the top collaborators of Mamoru Kyogashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoru Kyogashima. Mamoru Kyogashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamiya‐Koizumi, Keiko, Yurika Otoki, Kiyotaka Nakagawa, et al.. (2022). Cellular concentrations of plasmalogen species containing a polyunsaturated fatty acid significantly increase under hypoxia in human colorectal cancer, Caco2 cells. Biochemical and Biophysical Research Communications. 611. 1–7. 3 indexed citations
2.
Tanaka, Kouji, Keiko Tamiya‐Koizumi, Masaki Yamada, et al.. (2015). Hypoxia remodels the composition of the constituent ceramide species of HexCer and Hex2Cer with phytosphingosine and hydroxy fatty acids in human colon cancer LS174T cells. Glycoconjugate Journal. 32(8). 615–623. 5 indexed citations
3.
Kamijo, Yuji, Lixuan Wang, Akihiro Matsumoto, et al.. (2012). Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels. Clinical and Experimental Nephrology. 16(6). 959–967. 12 indexed citations
4.
Cao, Ke, Kouji Tanaka, Yuji Komizu, et al.. (2011). Hybrid liposomes affect cellular lipid constituents and caveolae structures. Bioorganic & Medicinal Chemistry Letters. 22(4). 1731–1733. 6 indexed citations
5.
Fujii, Masahiro, Yukihiro Yokoyama, Toshio Kokuryo, et al.. (2010). Cytoplasmic expression of the JM403 antigen GlcA-GlcNH 3 + on heparan sulfate glycosaminoglycan in mammary carcinomas—a novel proliferative biomarker for breast cancers with high malignancy. Glycoconjugate Journal. 27(7-9). 661–672. 6 indexed citations
6.
Inoue, Teruo, Isao Taguchi, Shichiro Abe, et al.. (2010). Sulfatides are associated with neointimal thickening after vascular injury. Atherosclerosis. 211(1). 291–296. 14 indexed citations
7.
Ito, Hiromi, Masashi Murakami, Kayo Yoshida, et al.. (2009). Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1789(11-12). 681–690. 42 indexed citations
8.
Zhang, Xiaowei, Takero Nakajima, Yuji Kamijo, et al.. (2009). Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides. Biochemical and Biophysical Research Communications. 390(4). 1382–1388. 26 indexed citations
9.
Kyogashima, Mamoru, Keiko Tadano‐Aritomi, Toshifumi Aoyama, et al.. (2008). Chemical and Apoptotic Properties of Hydroxy-Ceramides Containing Long-Chain Bases with Unusual Alkyl Chain Lengths. The Journal of Biochemistry. 144(1). 95–106. 15 indexed citations
10.
Hu, Rui, Yuji Kamijo, Toshifumi Aoyama, et al.. (2007). Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glycoconjugate Journal. 24(9). 565–571. 36 indexed citations
11.
Kyogashima, Mamoru, Keiko Tamiya‐Koizumi, Takashi Ehara, et al.. (2006). Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS. Glycobiology. 16(8). 719–728. 40 indexed citations
13.
Kyogashima, Mamoru. (2004). The role of sulfatide in thrombogenesis and haemostasis. Archives of Biochemistry and Biophysics. 426(2). 157–162. 34 indexed citations
14.
Kyogashima, Mamoru, et al.. (2001). Roles of galactose and sulfate residues in sulfatides for their antagonistic functions in the blood coagulation system. Glycoconjugate Journal. 18(3). 245–251. 14 indexed citations
15.
Inaba, Yuji, Motoki Ichikawa, Chang-Sung Koh, et al.. (1999). Suppression of Experimental Autoimmune Encephalomyelitis by Dermatan Sulfate. Cellular Immunology. 198(2). 96–102. 9 indexed citations
17.
Kyogashima, Mamoru, Makoto Inoue, Akira Seto, & Jin‐ichi Inokuchi. (1996). Glucosylceramide synthetase inhibitor, d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cells. Cancer Letters. 101(1). 25–30. 11 indexed citations
18.
Kyogashima, Mamoru, Makoto Inoue, Takahiro Isono, Jun Nakayama, & Akira Seto. (1994). Monoclonal antibody E6G6 recognizes glycolipids as a differentiation antigen in Shope carcinoma cells. Cancer Letters. 81(2). 221–228. 2 indexed citations
19.
Kyogashima, Mamoru, Makoto Inoue, Jun Nakayama, & Akira Seto. (1992). Aberrant expression of blood group H-antigen in Shope carcinoma cells. Cancer Letters. 66(3). 175–181. 2 indexed citations
20.
Kyogashima, Mamoru, James L. Mulshine, R. Ilona Linnoila, et al.. (1989). Antibody 624H12, which detects lung cancer at early stages, recognizes a sugar sequence in the glycosphingolipid difucosylneolactonorhexaosylceramide (V3FucIII3FucnLc6Cer). Archives of Biochemistry and Biophysics. 275(1). 309–314. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026